In March 2025, the company declared new designs for the direct-to-client supplying of its Wegovy weight loss drug. The company founded a fresh pharmacy, termed NovoCare, which might demand customers $499 monthly for entry to the drug, less than half the cost of the drug by way of other pharmaceu